Stock listing
LSE:0H8T Aclaris Therapeutics, Inc. Share Price
UK listing (LSE) of Aclaris Therapeutics, Inc. · home listing NASDAQ:ACRS
Follow Aclaris Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · LSE:0H8T
$3.83 USD +0.14 (+3.7%)
Close on Oct 27, 2026
- Day range
- $3.33 – $3.98 USDOct 27, 2026
- Volume
- 17,623 sharesOct 27, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ACRS · Home | $3.80 USD | -0.17 (-4.3%) | 1,644,578 | $4.085 | $4.085 | $3.765 | $3.97 | Close on Nov 2, 2026 |
| LSE:0H8T | $3.825 USD | +0.135 (+3.7%) | 17,623 | $3.69 | $3.985 | $3.33 | $3.69 | Close on Oct 27, 2026 |
| Frankfurt:8AT | €3.444 EUR | +0.094 (+2.8%) | — | €3.444 | €3.444 | €3.444 | €3.35 | Close on Oct 30, 2026 |
- Ticker
- LSE:0H8T
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- LSE
- Currency
- USD
What changed lately
Latest news release · Oct 27, 2026
Aclaris Therapeutics Announces Pricing of $50.0 Million Offering of Common Stock and Pre-Funded Warrants
Latest deck · Oct 27, 2026
Technical Presentation (October 2026)
Technical · 34 slides
Calls
Replays
Aclaris Therapeutics (NASDAQ:ACRS) Q1 2024 Earnings Call
Tue, May 07, 2024 · 5:00 PM ET
Watch TranscriptAclaris Therapeutics (NASDAQ:ACRS) Q1 2023 Earnings Call
Mon, May 08, 2023 · 8:00 AM ET
Watch Transcript
Latest news
Financings
Public offering of common stock and pre-funded warrants
Oct 27, 2026
Announced: about US$50M · US$3.5 a share · Leerink Partners +3
Dealers: Leerink Partners (co-lead), Piper Sandler (co-lead), Cantor (co-lead), LifeSci Capital (co-lead)
Buyers: TCGX; RA Capital Management; Invus
Decks
Technical Presentation (October 2026)
Technical · 34 slides · Oct 27, 2026
Investor Presentation (August 2026)
Investor deck · 33 slides · August 2026
Corporate Update (April 2026)
Corporate update · 30 slides · Apr 28, 2026
Investor Presentation (January 2026)
Investor deck · 65 slides · Jan 12, 2026
Aclaris Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 23 in the last 12 months · 132 in all · newest Oct 27, 2026 · oldest 2019
- Calls
- 2 calls with a replay · 2 with a transcript · latest May 7, 2024
- Decks
- 41 decks · latest Oct 27, 2026
Where Aclaris Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ACRS · Home listing | NASDAQ | United States | USD |
| gettex:8AT | gettex | Germany | EUR |
| Tradegate:8AT | Tradegate | Germany | EUR |
| LS Exchange:A1412H | LS Exchange | Germany | EUR |
| Lang & Schwarz:A1412H | Lang & Schwarz | Germany | EUR |
| LSE:0H8T · This page | LSE | United Kingdom | USD |
| BOATS:ACRS | BOATS | United States | USD |
| Stuttgart:8AT | Stuttgart | Germany | EUR |
| Dusseldorf:8AT | Dusseldorf | Germany | EUR |
| Frankfurt:8AT | Frankfurt | Germany | EUR |
| Munich:8AT | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Aclaris Therapeutics, Inc.